Cellectar Biosciences, Inc. (CLRB)
3.90
-0.08
(-2.01%)
USD |
NASDAQ |
Dec 09, 16:00
3.90
0.00 (0.00%)
After-Hours: 18:19
Cellectar Biosciences Total Assets (Quarterly): 14.63M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Imunon, Inc. | 8.988M |
| PDS Biotechnology Corp. | 34.71M |
| PAVmed, Inc. | 38.07M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.248M |
| Shareholders Equity (Quarterly) | 9.379M |
| Debt to Equity Ratio | 0.046 |
| Current Ratio | 2.773 |
| Net Debt Paydown Yield | 0.20% |